Programme: Tuesday, 14 November
08:00 – 11:00 | 243
Workshop: A Holistic Approach to Planning for a Digital Adherence Technology Intervention
Rachel Powers: Developing Differentiated Care Pathways
08:00 – 11:00 | 252AB
Agnes Gebhard: Chair
Mansa Mbenga: BPaL programmatic scale-up: Lessons Learned from BPaL implementation: considerations for developing a roadmap for the programmatic scale-up.
Veriko Mirtskhulava: Programmatic scale-up of BPaL/M Regimen: Monitoring end Evaluation Framework.
14:30 – 17:30 | 241
Workshop: Joint GLI-GDI Workshop: using BPaL/M, diagnostic and treatment aspects
Maria Imelda Quelapio: BPaL: Field experience in the Philippines under operational research
14:30 – 17:30 | 252AB
Chair: Petra de Haas
14:30 – 17:30 | 253
Maria Imelda Quelapio: Clinical aspects of the BPaLM/BPaL regimens and cost considerations
Programme: Wednesday, 15 November
10:15 – 11:45 | 242 B
Short Oral Abstract Session: Treatment and treatment outcomes of DR – TB
Maria Imelda Quelapio: Modifications on the BPaL regimen in under operational research in the Philippines
13:00 – 15:00 | Salle Maillot 5
TBScience E-Poster Session: Moderated E-Poster Session
Veriko Mirtskhulava: Antimicrobial resistance stewardship: lessons learned from drug-resistant tuberculosis programs – a scoping review
15:00 – 16:30 | 221M + 222
Oral Abstract Session: Safety of regimens for R-R
Veriko Mirtskhulava: Safety and effectiveness of the BPaL regimen: preliminary analysis of the first multi-country operational research cohort
15:00 – 16:30 | 231M + 232M
Short Oral Abstract Session: Access to quality TB care and services
Omotayo Salau: Strategic initiative to find people with tuberculosis (TB) among hospital attendees: unprecedented efforts to detect and notify additional TB cases in North Central, Nigeria
15:00 – 16:30 | 242 B
Short Oral Abstract Session: Diagnostics, including drug-resistance determination: Technical aspects and new developments
Chair: Kristin Kremer
15:00 – 16:30 | 252AB
Special session: The WHO’s new evidence-based guidelines on TB – how we can transform practice to accelerate TB eradication
Agnes Gebhard: Moderated panel discussion with Q&A
16:45 – 18:15 | 231M + 232M
Oral Abstract Session: How media can shape the message
Onyinye Kene-Eheh: Incentives as an effective TB communication tool: a case study of KNCV Nigeria’s Facebook page
16:45 – 18:15 | 253
Oral Abstract Session: Finding the missing children with TB
Ogoamaka Chukwuogo: Reversing the trend of low childhood TB diagnosis in Nigeria: the usefulness of stool-based Xpert testing
18:30 – 20:00 | 242B
Satellite Session: Digital adherence technologies in TB care: key results and lessons from the Adherence Support Coalition to End TB (ASCENT) trial
Chair: Kristian van Kalmthout
Adrian Leung: Process evaluation of ASCENT trials
Degu Dare: Key learnings from the ASCENT journey to enhance TB treatment outcomes through digital adherence technologies
Programme: Thursday, 16 November
08:30 – 10:00 | 202/203
Oral Abstract Session: Key Populations
Chair: Christiaan Mulder
08:30 – 10:00 | 221M + 222
Oral Abstract Session: CAD for Tuberculosis
Sani Useni: An analysis of the impact of portable digital X-ray on TB screening in hard-to-reach communities in Nigeria
Mustapha Tukur: Use of artificial intelligence to analyse chest X-rays for TB: Results from pilot studies of two independent softwares
08:30 – 10:00 | 252AB
Short Oral Abstract Session: Integrated services for TB case finding
Kenneth Ekpen: Improving TB case-finding through community interventions using the Wellness-on-Keke Model in Nigeria
10:15 – 11:45 | 242B
Oral Abstract Session: Strategies to improve active case finding
Chidubem Ogbudebe: Improving TB detection through targeted active TB screening using a peer-network hub strategy in Nigeria
Ogoamaka Chukwuogo: Systematic screening for TB disease using a combination of the WHO 4-symptom screening and chest X-ray with computer-aided detection in identified TB hotspot communities in Nigeria
15:00 – 16:30 | 202/203
Oral Abstract Session: Lessons learnt from the use of new technologies for TB prevention and care
Doris Ekpo: Programme benefits of using a localised performance tracker at the start of a project: TB-HIV integrated services in Lagos State, Nigeria
Ezinne Nwokoro: Lessons learnt from the SMS/USSD project implementation in Nigeria: the KNCV TB LON Regions 1 and 2 experience
15:00 – 16:30 | 252AB
Symposium: Urgent need for coordinated action to accelerate TB vaccine access
Chair: Joeri Buis
15:00 – 16:30 | 241
Oral Abstract Session: Validation of Diagnostics
Joseph Omame: Integrated TB and COVID-19 community intervention, a tool for improved TB case detection and COVID-19 vaccine uptake – the Bauchi state experience
15:00 – 16:30 | 253
Oral Abstract Session: Breaking down silos: Bidirectional TB and COVID screening
Chinenye Igwetu: Reducing missed opportunities in strengthening TB awareness in communities: leveraging COVID-19 vaccination campaigns in Taraba State, Nigeria
Aminu Babayi: Leveraging active TB case-finding using the Wellness-on-Keke intervention in the community to improve COVID-19 vaccine uptake in Nigeria
Degu Dare: Bi-directional screening strategies for TB and COVID-19 in Nigeria and the Philippines: case studies of two best practices
16:45 – 18:15 | 251
Oral Abstract Session: Models of Active Case Finding and Contact Investigation
Lotanna Ugochukwu: Strengthening intensified case-finding in public facilities without diagnostic tools using the healthcare worker model: an experience from Kano State, Nigeria
Yekumah Wali: Strategic integration of active TB case-finding into the COVID-19 vaccination programme – experience from the KNCV Nigeria GLOVAX Project in Anambra and Imo State, Nigeria
Programme: Friday, 17 November
07:15 – 08:15 | 252AB
Symposium: TB diagnostics, including drug-resistance determination – Technical aspects and new developments
Justin O’Grady (Oxford Nanopore Technologies): Chair
Kristin Kremer: The Dream Fund project on nanopore sequencing for tuberculosis and other infectious diseases in low- and middle-income countries; first experiences from Kyrgyzstan
08:30 – 10:00 | 243
Degu Dare: Chair
Sani Useni: Portable digital X-ray with AI to strengthen TB case-finding among key populations in Nigeria: an innovative public-private partnership scale-up model
10:15 – 11:45 | 242 A
Oral Abstract Session: TB: How much does it cost?
Dawit Getachew Assefa: Costs faced by TB patients in Ethiopia: a systematic review and meta-analysis
10:15 – 11:45 | 243
Symposium: Reaching agreement on the inclusion of pregnant and lactating persons in TB research
Mansa Mbenga: Chair
10:15 – 11:45 | 251
Jerod N. Scholten: Chair
Endale Mengesha: Multi-disease testing using GeneXpert® equipment: The Ethiopian experience
Carel Joseph: Molecular Multi disease testing platform till the periphery with WHO endorsed Rapid molecular testing (TrueNAAT) – fully domestic funded initiative from India
Fehinti Prisca Ajiboye: Implementation of multi-testing on the GeneXpert platform across Nigeria
15:00 – 16:30 | Amphitheatre Bleu
Symposium: The impact of digital adherence technologies on TB care: Results from ASCENT and other studies
Kristian van Kalmthout: Chair
Degu Dare: Effectiveness of digital adherence technologies in improving TB treatment: interim results from the ASCENT studies
15:00 – 16:30 | 202/203
Short Oral Abstract Session: Imaging for a TB free world
Mathew Fila: Portable digital X-ray and dynamics in active TB case-finding
Yekumah Wali: Concordance rate of expert reviews of PDX-CAD radiograph and molecular WHO-recommended rapid diagnostics for TB active case-finding in Delta State, Nigeria
15:00 – 16:30 | 242 B
Oral Abstract Session: Finding TB cases among vulnerable populations
Chidubem Ogdudebe: Evaluating the efficiency of active case-finding interventions to improve childhood TB in Nigeria
Ogoamaka Chukwuogo: Yield from active TB case-finding activities in prisons: implications for routine TB screening in Nigerian penitentiary institutions
15:00 – 16:30 | 243
Edine Tiemersma: Chair
16:45 – 18:15 | 231M + 232M
Oral Abstract Session: Digital methodologies in TB prevention and care
Chidubem Ogdudebe: The impact of hot-spot mapping on TB yield from community case-finding interventions: Experience from Nigeria
16:45 – 18:15 | 243
Short Oral Abstract Session: Global and local policies to Improve TB care and services
Degu Dare: Engaging key stakeholders from high-priority countries for strengthening research capacity to end TB: results from global stakeholder survey
Amina Kewa: Leveraging TB public health messaging to drive vaccination demand in local communities
16:45 – 18:15 | 253
Oral Abstract Session: Rapid tests for all TB cases
Endale Mengesha: High TB case notification through improved use of GeneXpert testing in Ethiopia
Ogoamaka Chukwuogo: Improving efficiency of the TB screening cascade: utility of a one-stop shop for TB diagnosis in the community
18:30 – 20:00 | 242 B
Satellite Session: Transforming evidence into practice – celebrating 120 years experience as inspiration for the future
Chairs: Kitty van Weezenbeek & Chakaya Muhwa
Maarten van Cleeff: The changing role of INGO’s in ending TB: Best practices from KNCV Tuberculosis Foundation
Mustapha Gidado: KNCV transformation from a national Dutch NGO to international network for elimination of TB
Agnes Gebhard: Innovation pathways: innovation – demonstration – scale-up
Kristin Kremer: Transforming the diagnostic landscape
Bethrand Odume: KNCV TB FOUNDATION NIGERIA – the journey to self-reliance
Programme: Saturday, 18 November
08:30 – 10:00 | 231M+232M
Satellite Session: TB diagnosis by molecular lens
Shalom Balogun: Lateral-flow urine lipoarabinomannan test for TB diagnosis in people living with HIV in Nigeria: a case study from the states of Benue and Taraba
08:30 – 10:00 | 241
Oral Abstract Session: TB Diagnosis for all and MWD for all
Nkiru Nwokoye: Impact of using WHO-recommended rapid molecular diagnostics in a mobile fashion for community active case-finding interventions: the KNCV Nigeria experience
08:30 – 10:00 | 252
Oral Abstract Session: Progress in TB case finding
Stephanie Gande: Evaluation of active TB case-finding among special populations in Bauchi State, Nigeria
10:15 – 11:45 | 243
Oral Abstract Session: Improving TB Diagnosis and Care
Yekumah Wali: The role of artificial intelligence in community active TB case-finding: a review of portable digital X-ray with computer-aided detection activities in Delta State, Nigeria
Husna Baffa: Is public-private mix the way to end the TB epidemic? A case study of patent medicine vendors in five high-burden local government areas in Kano, Nigeria
E-posters
- Experiences and lessons learnt in piloting stool Xpert testing in children in Kinshasa, DR Congo
- TrueNat, an effective diagnostic tool for detecting drug-resistant TB: A case study from the TB LON 1 and 2 Projects
Presenter Chineye Igwetu - Point-of-care programme in HIV, TB and associated conditions: A strategic global virtual initiative
Presenter: Degu Dare
- Four years of pharmacovigilance strengthening for drug-resistant TB in Eswatini, Ethiopia, Nigeria and Tanzania: Results from the PhArmacoVIgilance in Africa (PAVIA) project
Presenter: Edine Tiemersma - Optimising private sector TB prevention and care through the strategic engagement of private laboratories: The TB LON experience in Akwa-Ibom and Kano States, Nigeria
Presenter: Michael Sheshi - Spot to tent – using a systematic approach to contact investigation in Kano State, Nigeria
Presenter: Husna baffa - Patient and provider acceptability of digital adherence technologies for TB treatment in Ethiopia
- A new, versatile and open-source mathematical modelling framework applied to estimating the impact of novel TB vaccines
- Uptake of TB preventive therapy (3HR): experiences from Akwa Ibom, Cross River and River States, Nigeria
Presenter: Ifiok Ekanim - The Automated Partners Progress Report: Strengthening data-driven approach to TB case notification in Nigeria
- Cutaneous lesions of patients treated with BPaL in the Philippines under operational research
- Improving TB case-finding using optimised TB screening strategy among at-risk populations in Nigeria
Presenter: Sani Useni - Improving portable digital X-ray-driven active TB case-finding using the X-MAP system in Nigeria
Presenter: Kenneth Ekpen - Designing a TB elimination framework through participatory processes in Ethiopia: results from stakeholders’ discussions